Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage
Selena Gonzalez, Tyne L.M. McHugh, Tao Yang, et al.
Neurobiology of Disease (2021) Vol. 162, pp. 105563-105563
Open Access | Times Cited: 24

Showing 24 citing articles:

Neurotrophin-targeted therapeutics: A gateway to cognition and more?
Gunnar Nordvall, Pontus Forsell, Johan Sandin
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103318-103318
Open Access | Times Cited: 35
Targeting TrkB–PSD-95 coupling to mitigate neurological disorders
Xin Yang, Yu‐Wen Alvin Huang, John Marshall
Neural Regeneration Research (2024) Vol. 20, Iss. 3, pp. 715-724
Open Access | Times Cited: 6
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity‐dependent synaptic and microglial transcriptomic changes in a late‐stage Alzheimer's mouse model
Amira Latif‐Hernandez, Tao Yang, Robert R. Butler, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 7, pp. 4434-4460
Open Access | Times Cited: 4
Understanding How Physical Exercise Improves Alzheimer’s Disease: Cholinergic and Monoaminergic Systems
Boyi Zong, Fengzhi Yu, Xiaoyou Zhang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 16
Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease
Despoina Charou, Thanasis Rogdakis, Alessia Latorrata, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease
Ioanna Zota, Konstantina Chanoumidou, Achille Gravanis, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 3
Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity
Ya‐Jen Chiu, Te‐Hsien Lin, Kuo‐Hsuan Chang, et al.
Aging (2022) Vol. 14, Iss. 18, pp. 7568-7586
Open Access | Times Cited: 15
Pharmacological Co-Activation of TrkB and TrkC Receptor Signaling Ameliorates Striatal Neuropathology and Motor Deficits in Mouse Models of Huntington’s Disease
Danielle A. Simmons, Nadia P. Belichenko, Frank M. Longo
Journal of Huntington s Disease (2023) Vol. 12, Iss. 3, pp. 215-239
Open Access | Times Cited: 8
Neurotrophin growth factors and their receptors as promising blood biomarkers for Alzheimer’s Disease: a gene expression analysis study
Mohammad Reza Asadi, Jalal Gharesouran, Hani Sabaie, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer’s Disease
Olaia Martínez-Iglesias, Vinogran Naidoo, Iván Carrera, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2447-2447
Open Access | Times Cited: 12
Surfeit Locus Protein 4 as a Novel Target for Therapeutic Intervention in Cerebral Ischemia–Reperfusion Injury
Wenjie Hu, Xiangyi Kong, Yu Cui, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 4, pp. 2033-2048
Closed Access | Times Cited: 4
Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer’s Disease
Pontus Forsell, Cristina Parrado Fernández, Boel Nilsson, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 997-997
Open Access | Times Cited: 1
LM22B-10 promotes corneal nerve regeneration through in vitro 3D co-culture model and in vivo corneal injury model
Zekai Cui, Kai Liao, Shenyang Li, et al.
Acta Biomaterialia (2022) Vol. 146, pp. 159-176
Closed Access | Times Cited: 7
TNF‐α interference may ameliorate brain damage in neonatal hypoxic–ischemic encephalopathy rats by regulating the expression of NT‐3 and TRKC
Yong‐Min Niu, Steven Z. Du, Rong He
Ibrain (2023) Vol. 9, Iss. 4, pp. 381-389
Open Access | Times Cited: 3
Effects of central administration of the human Tau proteinon the <i>Bdnf, Trkb, p75, Mapt, Bax</i> and <i>Bcl-2</i> genes expression in the mouse brain
A. S. Oreshko, A. Ya. Rodnyy, Д. В. Базовкина, et al.
Vavilov Journal of Genetics and Breeding (2023) Vol. 27, Iss. 4, pp. 342-348
Open Access | Times Cited: 3
HDAC3 deacetylates H3K27ac and H3K9ac on the TrkC promoter to exacerbate sevoflurane-induced neurotoxicity
Jiegang Zhou, Xinwei Feng, Dan Wang
Molecular & Cellular Toxicology (2023) Vol. 20, Iss. 4, pp. 895-904
Closed Access | Times Cited: 2
Targeting neurotrophin and nitric oxide signaling to treat spinal cord injury and associated neurogenic bladder overactivity
Youko Ikeda, Irina Zabbarova, Pradeep Tyagi, et al.
Continence (2022) Vol. 1, pp. 100014-100014
Open Access | Times Cited: 3
Alternative Pharmacological Strategies for the Treatment of Alzheimer’s Disease: Focus on Neuromodulator Function
Grace Cunliffe, Yi Tang Lim, Woori Chae, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3064-3064
Open Access | Times Cited: 3
Specific Mode Electroacupuncture Stimulation Mediates the Delivery of NGF Across the Hippocampus Blood–Brain Barrier Through p65-VEGFA-TJs to Improve the Cognitive Function of MCAO/R Convalescent Rats
Mengyuan Dai, Kecheng Qian, Qinyu Ye, et al.
Molecular Neurobiology (2024)
Open Access
Modifications in the C-terminal tail of TrkC significantly alter neurotrophin-3-promoted outgrowth of neurite-like processes from PC12 cells
Paweł S. Krawczyk, Dagmara Kłopotowska, Janusz Matuszyk
Biochemistry and Biophysics Reports (2024) Vol. 40, pp. 101853-101853
Open Access
Multimodal beneficial effects of BNN27, a nerve growth factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s disease
Maria Kokkali, Kanelina Karali, Evangelia Thanou, et al.
Molecular Psychiatry (2024)
Open Access
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer’s mouse model
Amira Latif‐Hernandez, Tao Yang, Robert Raymond-Butler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s Disease
Despoina Charou, Thanasis Rogdakis, Alessia Latorrata, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s Disease.
Despoina Charou, Thanasis Rogdakis, Alessia Latorrata, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top